The chelating effect of zinc in patients with Covid 19

Phase 2

• Conditions: Condition 1: covid-19. Condition 2: covid-19. Condition 3: covid-19. Condition 4: covid-19.; Coronavirus infection, unspecified; Pneumonia due to SARS-associated coronavirus; Dyspnea; B34.2; Cough; R06.0; J12.81

• Registration Number: IRCT20210913052453N1
• Lead Sponsor: Asadabad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 November 2021

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Patients with Covid-19 admitted to the Intensive Care Unit (ICU)
Patients with Covid-19 with respiratory distress

Exclusion Criteria

insulin-dependent diabetic patients
Patients with urinary tract disorders
Patients with cardiovascular system disorders

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood oxygenation. Timepoint: At the beginning of the study, and 3 days after the study. Method of measurement: Evaluation of blood factors and clinical condition of the patient.